The New Science—genomics and biotechnology—and the New Technology—supercomputing, robotics, nanotechnology and the Internet—are transforming American society. No sector of American culture and economics has been more profoundly impacted by the confluence of these developments than the nation's healthcare system. Supercomputing is driving the sequencing of the human genome. Genomics and biotechnology are transforming the pharmaceutical enterprise. Pharmaceutical costs and quality are of paramount concern to America's employers, health plans, health systems and physicians. The Internet is fundamentally changing the manner by which pharmaceuticals are marketed and distributed, and the ways that healthcare providers communicate and seek to manage pharmaceutical costs. Pharmaceutical coverage and the regulation of patient privacy are defining issues in the nation's presidential campaign.

The Second Annual National Congress on the Future of Genomics, Biotechnology and Pharmaceuticals in Medical Care convenes a faculty of the nation's preeminent leaders in the field to identify and analyze the trends that will transform the nation and its health system in the coming years.

Congress Learning Objectives

• An Overview of the Status of the Mapping of the Human Genome and Likely Resulting Biotech and Pharmaceutical Products
• An Understanding of the Role of Super Computing and the Internet in Pharmaceutical Research, Development and Marketing
• Strategies Employed to Ensure Quality and Avoid Medical Errors and to Implement Effective Cost Containment Initiatives
• A Review of the Regulatory Setting for Genomics, Biotechnology and Pharmaceuticals
• The Role of Wall Street and the Silicon Valley in Financing Biotech and Pharmaceutical Ventures
• Pharmaceutical Policy Alternatives for the New Administration and Congress

Target Audience The Congress will be attended by the following individuals and institutional representatives: Health Care Executives and Board Members Health Plan, Health Systems and Physician Organization Medical Directors Physicians Pharmacists Registered Nurses Purchasers, including Private Employers and Public Purchasers Pharmaceutical Manufacturers Generic Pharmaceutical Manufacturers Site Management Organizations Clinical Research Organizations Pharmacy Benefit Management Companies Health Plans and Health Insurers Pharmaceutical Consultants Investment Bankers and Venture Capitalists Members of Congress and Staff Health Care Regulators and Policy Makers Health Services Researchers and Academics